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AIM: SYNTAX (SX) score is related to increased mortality in the course of acute ST
elevation myocardial infarction. SX score is expected to be higher in elderly patients.
We investigated the effect of SX score which is already elevated over short and longC222 JACC Voterm adverse cardiovascular events (death, stroke, reinfarction and rehospitalization)
in patients treated with primary percutaneous coronary intervention (p-PCI).
Study Design: The presented study has a retrospective data collection and prospective
follow-up design. The study population consisted of 607 elderly (70) patients who
admitted to our emergency department within ﬁrst 12 hours of chest pain between
January 2006-February 2010 and underwent p-PCI. The patients were investigated in
3 groups according to baseline SX score (Tertile I <15, n¼213), tertile II 15-20,
n¼243, tertile III >20, n¼151).
Results: SX score (12.12.1 vs 18.11.7 vs 24.84.5, p<0.001, respectively) and
age (72.94.1 vs 74.74.4 vs 76.94.7, p<0.001) were signiﬁcantly higher in the
tertile III group. Also diabetes and chronic renal failure were more common, C-
reactive protein level on admission was signiﬁcantly higher and post procedural left
ventricular ejection fractions were signiﬁcantly lower in tertile III group. While in
hospital mortality was highest in tertile III (13.9% vs 7.8% vs 5.2%, p¼0.011), stroke
and reinfarction rates were similar between three groups. During long term follow-up
(53 months median follow-up time) all cause mortality (49% vs 30.9% vs 20.2%,
p<0.001, respectively), reinfarction (14.4% vs 8.5% vs 6.4%, p¼0.042, respectively),
stroke (6.8%, vs 3.6%, vs 1.5%, p¼0.04, respectively) and rehospitalization due to
worsening heart failure (16.8% vs 12.2% vs 8%, p¼0.049, respectively) were
signiﬁcantly higher in the tertile III group. High SX score (tertile III) was an inde-
pendent predictor of long term all cause mortality in the Cox-proportional hazard
model (Hazard Ratio 1.97, 95% CI 1.26 – 3.09, p¼ 0.003).
Conclusıon: Elevated SX score is related to increased in-hospital and long term all
cause mortality and ischemic events in elderly pateints and it is an independent
predictor of mortality.
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Background: Periprocedural Myonecrosis (PPMN) during percutaneous coronary
intervention (PCI) is common and related with adverse cardiac event. However there
are limited data about the PPMN predictors. The aim of this study was to investigate
the ability of SNTAX score to predict PPMN in patients undergoing elective PCI for
stable angina.
Methods: A total of 172 patients with stable angina scheduled for elective PCI was
included the study. Cardiac Troponin I (cTnI) levels were measured at baseline and at
6, 12, 24 and 48 hours after PCI. The primary end-point was the occurrence of PPMN
deﬁned as any cTnI elevation above the Upper Normal Limit (UNL). The occurrence
of Periprocedural Myocardial Infarction (PPMI), was deﬁned as a postprocedural
increase in cTnI level 5 times above the UNL.
Results: The incidence of PPMN was 22.7% (39 of 172 patients) and the incidence of
PPMI was 4.7% (8 of 172 patients). Mean patient SYNTAX score was higher in
patients with PPMN (13.26.7 vs. 9.55.2, p<0.001) and PPMI (16.57.2 vs
10.05.6, p¼0.002). By ROC analysis, a patient SYNTAX score of 11 predicted
PPMN with a sensitivity of 64% and speciﬁcity of 65%, the AUC 0.660.05 (95% CI:
0.55 – 0.77); p¼0.002, a patient SYNTAX score of 15 predicted PPMI with
a sensitivity of 75% and speciﬁcity of 78%, the AUC 0.760.09 (95% CI: 0.56 –
0.95); p¼0.01. The SYNTAX score was a signiﬁcant predictor for PPMN in
univariate (OR:1.11 (95% CI: 1.04 – 1.18); p¼0.001) and multivariate (OR:1.10 (95%
CI: 1.03 – 1.17); p¼0.003) logistic regression analysis.
Conclusıon: This trial demonstrated that higher SYNTAX score is a signiﬁcant
predictor of PPMN and PPMI.
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Introductıon: Quality of life has become an important outcome measure in addition
to mortality and morbidity in patients with congenital heart disease. Atrial septal
defect (ASD) is a common congenital heart disease and transcatheter ASD closure has
become an accepted treatment modality. The aim of this study is to assess the quality
of life of ASD patients who underwent percutaneous closure.
Materıals-Methods: We examined the quality of life of 69 ASD patients and 69
healthy controls matched according to age, sex, educational level, economic, marital
and employment status (1:1 matching). Quality of life was investigated by the Turkish
version of Short Form-36 (SF-36).
Results: The mean age of the patients was 39.714.2 and 26% were male. The quality
of life assessment was performed at a mean follow-up time of 18.013.8 months after
the intervention. Thirty one percent of the patients reported atypical chest pain, 16%
reported palpitations and 11% reported shortness of breath at the time of quality of life
assessment. Patients who had palpitations were further investigated with holterl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
Table 1
Variable Pre-PTRAS Post-PTRAS p
SP 153.0417.07 124.7511.40 <0.001
Men 146.9215.88 124.089.00 <0.001
Women 158.3316.76 125.3313.43 <0.001
DP 92.5010.76 77.548.23 <0.001monitoring and no serious arrhythmia was detected. The mean scores of the domains
of the SF-36 namely, physical functioning, role functioning, social functioning, mental
health, vitality, pain and general health were similar in ASD patients and the control
group (Table 1). The only sociodemographic variable that was found to be associated
with quality of life outcome parameters in the patient group was educational level.
Higher educational level was signiﬁcantly associated with better mental health and
better general health perception (r¼0.248, p¼0.04; r¼0.315, p¼0.008, respectively).
Conclusıon: Adult patients who underwent percutaneous ASD closure perceive their
quality of life as good as their healty counterparts.Table 1
ASD patiens Control group p value
Physical
functioning
73.820.7 73.927.3 0.97
Role physical 67.441.2 69.240.2 0.79
Pain 64.325.5 61.725.6 0.55
General health 60.525.3 62.320.8 0.64
Vitality 56.321.2 55.220.9 0.76
Social functioning 74.922.9 73.322.8 0.69
Role emotional 63.639.9 62.241.9 0.84
Mental health 63.719.0 63.617.5 0.96
The SF-36 domain scores in ASD patients and the control group.
Men 87.318.81 76.317.93 0.001
Women 97.0010.49 78.608.60 <0.001
Number of drug 3.710.85 2.460.69 <0.001
Men 3.850.80 2.310.75 <0.001
Women 3.600.91 2.600.63 0.006
Creatinine 1.130.31 1.130.31 0.150
Men 1.410.53 1.170.32 0.088
Women 1.150.42 1.100.30 0.767
eGFR 60.8935.21 61.7521.08 0.899
Men 62.7731.31 70.6922.94 0.300
Women 59.2739.30 54.0016.37 0.632
Table 2: Pre-Percutaneous transluminal renal angioplasty with stent (PTRAS) and at 6 month
follow up results of blood pressure, medications, creatinine and estimated glomerular ﬁltra-
tion rate. Abbrevations: PTRAS, percutaneous transluminal renal artery stenting; SP, systolic
blood pressure; DP, diastolic blood pressure; eGFR, estimated glomerular ﬁltration rate.
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Background and AIM: Metabolic syndrome (MS) is associated with cardiovascular
mortality and morbidity in patients with acute coronary syndrome. The purpose of this
studywas to evaluate the impact ofMSon long-termclinical outcomes in patientswithpure
non-ST segment myocardial infarction (NSTEMI) or unstable angina pectoris (USAP).
Methods-Results: We prospectively enrolled 310 consecutive NSTEMI/USAP patients
(74 females;meanage, 59.311.9years).The studypopulationwasdivided into twogroups:
MS(+) and MS(-). The clinical outcomes of the patients were followed for up to 3 years.
Increased 3-year cardiovascular mortality and reinfarction were observed in the
MS(+) group, as compared to theMS(-) group (15 vs. 3.4%, p¼0.001, and 22.2 vs. 8.3%,
p¼0.001, respectively). Hospitalization rates for heart failure and stroke were not
signiﬁcantly different between the two groups on follow-up. By a Cox multivariate
analysis, a signiﬁcant association was noted between MS and the adjusted risk of 3-year
cardiovascular mortality (odds ratio 3.4, 95% conﬁdence interval, 1.24-9.1, p¼0.02).
Conclusıon: These results suggest that MS is associated with an increased risk of 3-
year cardiovascular mortality and reinfarction in patients with NSTEMI/USAP.
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Objectıves: Atherosclerotic renal artery stenosis (ARAS) is associated with uncon-
trolled hypertension and chronic renal failure. The aim of this study is to evaluate the
inﬂuence of gender and presence of chronic renal failure on the outcomes of percu-
taneous transluminal renal artery stenting (PTRAS) due atherosclerosis.
Methods: A total of 28 ARAS patients underwent PTRAS and 36 stents were placed.
Basal characteristics, laboratory data and blood pressure of patients were recorded.
The differences between genders and improvement/deterioration of renal functions
and blood pressure were analyzed. The predictors of outcomes were determined.
Results: Baseline characteristics were similar between men and women. Signiﬁcant
improvement of systolic and diastolic blood pressure control was achieved after
PTRAS (153.0417.07 mmHg vs. 124.7511.40 mmHg, p¼0.001 and 92.5010.76
mmHg vs. 77.548.23 mmHg, p<0.001, respectively) (Table-1). Although mean
estimated glomerular ﬁltration rate (eGFR) and creatinine levels did not signiﬁcantly
improved at 6 month follow up visit in compared to baseline values, of the 28 patients
13 (46.4%) patients had improvement of renal functions.
Conclusıon: Our results suggests that PTRAS is a safe procedure and may offer blood
pressure control but beneﬁcial effects of PTRAS on renal function may be anticipated
in selected group of patients, especially those with a low eGFR.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTPP-359
Comparison of Carvedilol, Nebivolol and Metoprolol for the Prevention of
Contrast Induced Nephropathy
Çagdas¸ Akgüllü, Ufuk Eryılmaz, Ahmet Huyut, Tolga Hekim, Hasan Güngör,
Cemil Zencir
Adnan Menderes University Faculty of Medicine, Department of Cardiology, Aydin
Background: Metoprolol, carvedilol and nebivolol were different beta blockers with
different properties. In the literature there are various studies evaluating renal effects
of these beta blockers under different conditions. However, to the best of our
knowledge there is not any study comparing preventive effects of these three beta
blockers with each other against contrast induced nephropathy (CIN).
Aım: We aimed to investigate and compare the probable prophylactic effects of three
beta blocker agents, carvedilol, nebivalol and metoprolol against CIN.
Method: 184 patients who were hospitalized for further evaluation with coronary
angiography and have been using beta blocker agent (50 mg metoprolol, 25 mg
carvedilol or 5 mg nebivolol) at least for a week were enrolled to the study. Exclusion
criteria included dialysis patients, recent exposure to contrastmedia or a nephrotoxic
agent within 7 days before the study, urgent percutaneous coronary intervention (PCI),
requiring loop diuretics, theophylline/ aminophylline, dopamine throughout the study,
hemodynamically unstable patients. Patients were divided into three groups: meto-
prolol (M) (64 patient), nebivolol (N) (60 patient), carvedilol (C) (60 patient). All
groups were hydrated before and after the coronary procedure for 12 hours with the
rate of 1 ml/kg/hour intravenous isotonic saline. Serum cretainine (Cr) levels were
checked in the second and ﬁfth days of the study. The primary end point was the
occurence of CIN. We deﬁned CIN as an increase 0.5 mg/dL and/or 25% in serum
creatinine (SCr) concentration at day 2 and/or day 5 of the procedure.
Results: The distribution of various characteristics of the participants is shown in
Table 1and Table 2. Seven (10.9%) patients in group M developed CIN, as did 5
patients (8.3%) in group N and 2 patients (3.3%) in group C. Patients in carvedilol
group developed less CIN, however the difference with the group C and the others
did not reach statistical signiﬁcance (p¼0.283) (Figure 1). Changes in mean Cr
level from baseline to day 2 and day 5 were not statistically signiﬁcant in all groups.
Conclusıon: If there is indication for a beta blocker therapy before the coronary
angiography procedure, although the comperative results with metoprolol and nebi-
volol did not reach statistical signiﬁcance, this study demonstrated a weak evidence
favouring against carvedilol prescription as it would be a better choice for the
prevention of CIN.ERS C223
